Mammography Market (By Product: Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems, Others; By Technology: Breast Tomosynthesis Mammography,CAD Mammography, Digital Mammography; By Modality: Portable, Non-Portable; By End Use: Hospitals, Special Clinics, Diagnosis Centers, Ambulatory Surgical Centers, Educational & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

 

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Mammography Market 

5.1. COVID-19 Landscape: Mammography Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Mammography Market, By Product

8.1. Mammography Market, by Product, 2023-2032

8.1.1. Film Screen Systems

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Digital Systems

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Analog Systems

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Biopsy Systems

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. 3D Systems

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Mammography Market, By Technology

9.1. Mammography Market, by Technology e, 2023-2032

9.1.1. Breast Tomosynthesis Mammography

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. CAD Mammography

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Digital Mammography

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Mammography Market, By Modality 

10.1. Mammography Market, by Modality, 2023-2032

10.1.1. Portable

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Non-Portable

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Mammography Market, By End Use 

11.1. Mammography Market, by End Use, 2023-2032

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Special Clinics

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Diagnosis Centers

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Ambulatory Surgical Centers

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Educational & Research Institutes

11.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Mammography Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.3. Market Revenue and Forecast, by Modality (2020-2032)

12.1.4. Market Revenue and Forecast, by End Use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Modality (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End Use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Modality (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End Use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.3. Market Revenue and Forecast, by Modality (2020-2032)

12.2.4. Market Revenue and Forecast, by End Use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Modality (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End Use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Modality (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End Use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Modality (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End Use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Modality (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End Use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.3. Market Revenue and Forecast, by Modality (2020-2032)

12.3.4. Market Revenue and Forecast, by End Use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Modality (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End Use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Modality (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End Use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Modality (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End Use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Modality (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End Use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.3. Market Revenue and Forecast, by Modality (2020-2032)

12.4.4. Market Revenue and Forecast, by End Use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Modality (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End Use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Modality (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End Use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Modality (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End Use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Modality (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End Use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.3. Market Revenue and Forecast, by Modality (2020-2032)

12.5.4. Market Revenue and Forecast, by End Use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Modality (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End Use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Modality (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End Use (2020-2032)

Chapter 13. Company Profiles

13.1. Hologic

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Fujifilm

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Siemens Healthcare

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Phillips Healthcare

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Toshiba Medical Systems

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GE Healthcare

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Metaltronica

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. I.M.S. Srl

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Koninklijke Philips NV

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Gamma Medica, Inc

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

 

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample